Navigation Links
PharmaNet Launches New Brand Identity at Upcoming Industry Conferences
Date:11/15/2010

PRINCETON, N.J., Nov. 15, 2010 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, announced today that it is launching a new brand identity and tagline, "PharmaNet Works For You".  The new brand and tagline reflect the Company's promise to its clients to provide intelligent solutions to accelerate drug development programs consistent with the highest standards of regulatory compliance, quality and reliability.

The new branding unifies PharmaNet's messaging across all of its subsidiaries and services, and clearly articulates the entire Company's commitment to client service around the world. PharmaNet has the global reach and experience to execute clinical development programs from small local projects to large global programs with a custom-fit philosophy that provides a personalized approach to client service.

PharmaNet's new brand identity has already appeared in a pre-launch advertising campaign running in digital and print industry publications. It will be formally launched at two upcoming industry events, the 2010 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in New Orleans, Louisiana, from November 14-18 and the 9th Annual Partnerships in Clinical Trials Conference in Vienna, Austria, from November 16-19.  

"The trusted PharmaNet name now serves as the umbrella brand for all our global clinical development service offerings, from bioequivalence and bioanalytical services to Phase I – IV programs," said Jeffrey P. McMullen, Chief Executive Officer, PharmaNet.

"We have taken on this initiative to strengthen and modernize our brand into one voice," Mr. McMullen explained. "This investment in PharmaNet's future demonstrates commitment to our clients and provides a solid foundation for our continued expansion of services, geographies, and capabilities."  

About PharmaNet Development Group, Inc.PharmaNet Development Group, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet Works For You. For more information, please visit www.PharmaNet.com.Contact: Anne-Marie HessPhone:   (609) 951-6842E-mail:   ahess@pharmanet.com
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharmaNet Development Group Announces Observational Research Survey
2. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
3. PharmaNet Development Group Symposia Crossing the Bridge from Preclinical to Clinical Studies to be Held February 2010 in Basel, Dusseldorf and Vienna
4. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
5. PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam
6. Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance
7. PharmaNet Development Group To Showcase Innovative Solutions and Poster Presentations at AAPS 2009
8. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
9. World-Renowned Singer Youssou NDour Launches NightWatch Program
10. CRi Launches the TRIO™ Multispectral Imaging System for Multi-Analyte Investigation in Tissue
11. IntegenX Launches the Apollo 324 System for Automated DNA Library Preparation at the ASHG Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids this ... by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited about ... ages; it is a non-competitive, non-timed event, which is all about having fun and ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
Breaking Medicine News(10 mins):